<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(8)</volume><submitter>Okonkwo OC</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>Black or African American (hereinafter, Black) and Hispanic or Latino/a/x (hereinafter, Latinx) adults are disproportionally affected by Alzheimer disease, but most research studies do not enroll adequate numbers of both of these populations. The Alzheimer's Disease Neuroimaging Initiative-3 (ADNI3) launched a diversity taskforce to pilot a multipronged effort to increase the study inclusion of Black and Latinx older adults.&lt;h4>Objective&lt;/h4>To describe and evaluate the culturally informed and community-engaged inclusion efforts to increase the screening and enrollment of Black and Latinx older adults in ADNI3.&lt;h4>Design, setting, and participants&lt;/h4>This cross-sectional study used baseline data from a longitudinal, multisite, observational study conducted from January </pubmed_abstract><journal>JAMA network open</journal><pagination>e2427073</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11316236</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce.</pubmed_title><pmcid>PMC11316236</pmcid><pubmed_authors>Diaz A</pubmed_authors><pubmed_authors>Salloway S</pubmed_authors><pubmed_authors>Farlow MR</pubmed_authors><pubmed_authors>Okonkwo OC</pubmed_authors><pubmed_authors>Ances BM</pubmed_authors><pubmed_authors>Strong J</pubmed_authors><pubmed_authors>Rogalski EJ</pubmed_authors><pubmed_authors>Alzheimer’s Disease Neuroimaging Initiative</pubmed_authors><pubmed_authors>Soto AM</pubmed_authors><pubmed_authors>Rivera Mindt M</pubmed_authors><pubmed_authors>Miller MJ</pubmed_authors><pubmed_authors>Conti C</pubmed_authors><pubmed_authors>Beigi MR</pubmed_authors><pubmed_authors>Shah RC</pubmed_authors><pubmed_authors>Aisen PS</pubmed_authors><pubmed_authors>Doraiswamy PM</pubmed_authors><pubmed_authors>Sabbagh MN</pubmed_authors><pubmed_authors>Flenniken D</pubmed_authors><pubmed_authors>Grossman HT</pubmed_authors><pubmed_authors>Ashford MT</pubmed_authors><pubmed_authors>Schneider LS</pubmed_authors><pubmed_authors>Duara R</pubmed_authors><pubmed_authors>Reist C</pubmed_authors><pubmed_authors>Petersen RC</pubmed_authors><pubmed_authors>Raman R</pubmed_authors><pubmed_authors>Donohue MC</pubmed_authors><pubmed_authors>Weiner MW</pubmed_authors><pubmed_authors>Mintzer JE</pubmed_authors><pubmed_authors>Nosheny RL</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce.</name><description>&lt;h4>Importance&lt;/h4>Black or African American (hereinafter, Black) and Hispanic or Latino/a/x (hereinafter, Latinx) adults are disproportionally affected by Alzheimer disease, but most research studies do not enroll adequate numbers of both of these populations. The Alzheimer's Disease Neuroimaging Initiative-3 (ADNI3) launched a diversity taskforce to pilot a multipronged effort to increase the study inclusion of Black and Latinx older adults.&lt;h4>Objective&lt;/h4>To describe and evaluate the culturally informed and community-engaged inclusion efforts to increase the screening and enrollment of Black and Latinx older adults in ADNI3.&lt;h4>Design, setting, and participants&lt;/h4>This cross-sectional study used baseline data from a longitudinal, multisite, observational study conducted from January </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2025-04-22T14:44:38.293Z</modification><creation>2025-04-06T01:10:06.128Z</creation></dates><accession>S-EPMC11316236</accession><cross_references><pubmed>39120898</pubmed><doi>10.1001/jamanetworkopen.2024.27073</doi></cross_references></HashMap>